Özet:
An outbreak of a new type coronavirus (COVID-19) disease firstly emerged in Wuhan City, China in December 2019, rapidly spreads
across the globe. COVID-19 predisposes a procoagulant state in severe COVID-19 cases with a significant increase in the incidence
of venous thromboembolism, including both pulmonary embolism and deep vein thrombosis that appear to be associated with
excessive inflammation, hypoxia, immobilization, and diffuse intravascular coagulation. As the thromboembolic risk of COVID-19
patients at home is not known, a risk assessment model for thrombosis may also be considered in these patients. Herein, we present
a patient with mild COVID-19 infection who developed acute deep vein thrombosis.
